Here is My Question:
What do you know about the EMBOLD A188 trial and it’s promise of demyelination? How far off might we be? Any chance to be included in the phase 3?
EMBOLD is currently recruiting patients for the phase 2 portion of the study. UCSD is a clinical trial site for this study. Follow the link pasted below to learn more about the study and to contact Atara Biotherapeutics about a study site near your residence. If you live in San Diego County, UCSD is one of the study sites for the EMBOLD study. You need an appointment with either me or Dr Jennifer Graves to be evaluated for this study. The main entry criterion is progressive multiple sclerosis and age less than 61.
Revere P (Rip) Kinkel, MDProfessor of Clinical Neurosciences
Director of the Multiple Sclerosis Program
Clinical Neurosciences Director
University of California San Diego
PLEASE NOTE: This information/opinions on this site should be used as an information source only. This information does not create any patient-HCP relationship, and should not be used as a substitute for professional diagnosis and treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.